Complaint·June 17, 2026

LPA also called R1’s physician to verify R1’s statement but was unsuccessful. Additional interviews were conducted and the information obtained revealed that Staff reported that the only medication- related concern they recall involving R1 occurred when R1 was prescribed an antibiotic eye drop. Staff stated that when they informed R1 about the new medication and read the prescription label to them, R1 declined to take it, stating they were allergic to sulfates. Staff reported that they immediately notified the prescribing provider of R1’s allergy concern and requested the medication to be discontinued. Staff stated that the medication was discontinued within two days and confirmed that no doses were administered during that time. A review of R1's chart confirmed statement given by facility’s staff. Regarding R1’s psychotropic medication (M1), staff reported that R1 has always been prescribed 3 mg at bedtime, administered as one whole tablet, and not as a partial dose. LPA reviewed R1’s MAR and confirmed that M1 was dispensed at a consistent dosage of 3 mg. LPA also reviewed pictures provided by R1 and confirmed that pills were not cut. Based on the information obtained, the allegation is UNSUBSTANTIATED. A finding that the complaint is UNSUBSTANTIATED means the allegation may have happened or is valid, but there is not a preponderance of the evidence to prove that the alleged violation occurred. An exit interview was conducted and a copy of this report was provided to Business Office Manager Nicole Kalacas.